{"answer":{"query":"entresto","resolved_as":"name","packages":17,"applications":["NDA207620","NDA218591"],"identity":{"application_numbers":["NDA207620","NDA218591"],"marketing_categories":["NDA"],"labelers":[{"text":"NOVARTIS PHARMACEUTICALS CORPORATION","untrusted":true},{"text":"NOVARTIS","untrusted":true}],"dosage_forms":[{"text":"TABLET, FILM COATED","untrusted":true},{"text":"PELLET","untrusted":true}],"marketing_start":{"earliest":"2015-07-07","latest":"2024-04-12","packages_with_a_start_date":11}},"price":{"median_negotiated_over_nadac":0.4515,"packages_compared":8,"packages_listed":17,"negotiated_price_ends":"2026-12-31","rows":[{"ndc":"00078065920","name":{"text":"ENTRESTO FCT 24MG/26MG 60","untrusted":true},"class":"B","nadac_per_unit":11.59231,"negotiated_per_unit":5.226585,"ratio":0.451,"ful_per_unit":0.521626},{"ndc":"00078065935","name":{"text":"ENTRESTO FCT 24MG/26MG 10X10 HUD","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":5.226585,"ratio":null,"ful_per_unit":null},{"ndc":"00078065961","name":{"text":"ENTRESTO FCT 24MG/26MG (blister)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":5.226585,"ratio":null,"ful_per_unit":null},{"ndc":"00078065967","name":{"text":"ENTRESTO FCT 24MG/26MG 180","untrusted":true},"class":"B","nadac_per_unit":11.59231,"negotiated_per_unit":5.226585,"ratio":0.451,"ful_per_unit":0.521626},{"ndc":"00078069620","name":{"text":"ENTRESTO FCT 97MG/103MG 60","untrusted":true},"class":"B","nadac_per_unit":11.59281,"negotiated_per_unit":5.225027,"ratio":0.451,"ful_per_unit":0.791607},{"ndc":"00078069635","name":{"text":"ENTRESTO FCT 97MG/103MG 10X10 HUD","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":5.225027,"ratio":null,"ful_per_unit":null},{"ndc":"00078069661","name":{"text":"ENTRESTO FCT 97MG/103MG (blister)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":5.225027,"ratio":null,"ful_per_unit":null},{"ndc":"00078069667","name":{"text":"ENTRESTO FCT 97MG/103MG 180","untrusted":true},"class":"B","nadac_per_unit":11.59281,"negotiated_per_unit":5.225027,"ratio":0.451,"ful_per_unit":0.791607},{"ndc":"00078077720","name":{"text":"ENTRESTO FCT 49MG/51MG 60","untrusted":true},"class":"B","nadac_per_unit":11.56125,"negotiated_per_unit":5.225405,"ratio":0.452,"ful_per_unit":0.719882},{"ndc":"00078077735","name":{"text":"ENTRESTO FCT 49MG/51MG 10X10 HUD","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":5.225405,"ratio":null,"ful_per_unit":null},{"ndc":"00078077761","name":{"text":"ENTRESTO FCT 49MG/51MG (blister)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":5.225405,"ratio":null,"ful_per_unit":null},{"ndc":"00078077767","name":{"text":"ENTRESTO FCT 49MG/51MG 180","untrusted":true},"class":"B","nadac_per_unit":11.56125,"negotiated_per_unit":5.225405,"ratio":0.452,"ful_per_unit":0.719882},{"ndc":"00078123120","name":{"text":"ENTRESTO SPRINKLE  6MG/6MG ORAL PELLETS","untrusted":true},"class":"B","nadac_per_unit":11.6248,"negotiated_per_unit":5.521349,"ratio":0.475,"ful_per_unit":null},{"ndc":"00078123820","name":{"text":"ENTRESTO SPRINKLE 15MG/16MG ORAL PELLETS","untrusted":true},"class":"B","nadac_per_unit":11.60625,"negotiated_per_unit":5.648068,"ratio":0.487,"ful_per_unit":null},{"ndc":"71610080632","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"71610080737","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"71610081032","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null}],"negotiated_scheduled":null},"generic_entry":[{"application":"NDA207620","date":"2036-05-09","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"11058667","productNo":"001"},"latest_patent_expiry":"2036-05-09","latest_exclusivity_expiry":"NOT_PROVIDED","dated_barriers":24,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":6,"exclusivities_listed":0,"fact_id":"d04f83c22b9155c5b659947d"},{"application":"NDA218591","date":"2037-02-02","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"10722471","productNo":"002"},"latest_patent_expiry":"2037-02-02","latest_exclusivity_expiry":"NOT_PROVIDED","dated_barriers":6,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":3,"exclusivities_listed":0,"fact_id":"6a54be5fc708906e6f3b2fa8"}],"label_history":{"events_total":8,"non_cmc_events":4,"counts_by_class":{"EFFICACY":3,"LABELING":1},"cmc_events":4,"recent_non_cmc_events":[{"application":"NDA207620","submission_no":25,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2024-04-12","documents":[{"type":"Label","date":"2024-07-01","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218591Orig1s000,207620Orig1s025lbl.pdf","untrusted":true}},{"type":"Letter","date":"2024-04-15","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/218591Orig1s000,207620Orig1s025ltr.pdf","untrusted":true}}],"fact_id":"05b98feef4d821ffeb684051"},{"application":"NDA207620","submission_no":18,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2021-02-16","documents":[{"type":"Label","date":"2021-02-16","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207620s018lbl.pdf","untrusted":true}},{"type":"Letter","date":"2021-02-17","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/207620Orig1s018ltr.pdf","untrusted":true}}],"fact_id":"903cd5e68f69c3a2bd4d02ad"},{"application":"NDA207620","submission_no":13,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2019-10-01","documents":[{"type":"Label","date":"2019-10-02","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207620s013lbl.pdf","untrusted":true}},{"type":"Letter","date":"2019-10-02","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/207620Orig1s013ltr.pdf","untrusted":true}}],"fact_id":"3f53e5837713dac6563724f6"},{"application":"NDA207620","submission_no":8,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2017-11-22","documents":[{"type":"Label","date":"2017-11-24","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207620s008lbl.pdf","untrusted":true}},{"type":"Letter","date":"2017-11-27","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/207620Orig1s008ltr.pdf","untrusted":true}}],"fact_id":"008ddf1e3a6e9c667ae3613e"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":5,"te_code_counts":{"AB":3,"NOT_PROVIDED":2},"marketing_status_counts":{"Prescription":5},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"NDA207620","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"ENTRESTO","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"24MG;26MG","untrusted":true}},{"application":"NDA207620","product_no":"003","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"ENTRESTO","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"97MG;103MG","untrusted":true}},{"application":"NDA207620","product_no":"002","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"ENTRESTO","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"49MG;51MG","untrusted":true}},{"application":"NDA218591","product_no":"001","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"ENTRESTO SPRINKLE","untrusted":true},"form":{"text":"CAPSULE, PELLETS;ORAL","untrusted":true},"strength":{"text":"6MG;6MG","untrusted":true}},{"application":"NDA218591","product_no":"002","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"ENTRESTO SPRINKLE","untrusted":true},"form":{"text":"CAPSULE, PELLETS;ORAL","untrusted":true},"strength":{"text":"15MG;16MG","untrusted":true}}]},"supply":{"fda_shortage_status_counts":{},"packages_with_a_termination_date":6,"next_package_termination_dates":[],"packages_with_future_termination_date":0,"termination_meaning":"manufacturer-reported last-lot expiry or withdrawal date of one package; other packages and generics can remain"},"trials":{"attribution":"Source: ClinicalTrials.gov","modification_statement":"OmniRx has summarized and trimmed this ClinicalTrials.gov data.","not_an_offer":"A recruiting trial listing is not an offer of free drug and not medical advice; enrollment is decided by the study team.","ingredients":[{"ingredient":{"text":"valsartan","untrusted":true},"recruiting_interventional_count":31,"not_yet_recruiting_count":10,"by_phase":{"PHASE3":8,"PHASE1":4,"NA":4,"PHASE4":9,"PHASE2/PHASE3":2,"PHASE2":3,"PHASE1/PHASE2":1},"registry_processing_date":"2026-11-06T10:00:05","modifications":"Counts and phase tallies computed here from the full recruiting result set; trials trimmed to the 25 most recently updated, conditions to 3, countries to 10 distinct; no text edited.","recent_trials":[{"nct_id":"NCT02735707","title":{"text":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","untrusted":true},"phase":["PHASE3"],"sponsor":{"text":"UMC Utrecht","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-11-04","start_date":"2016-04-11","link":{"text":"https://clinicaltrials.gov/study/NCT02735707","untrusted":true}},{"nct_id":"NCT06693674","title":{"text":"Effect of Sacubitril-Valsartan on Cardiac Structure and Function","untrusted":true},"phase":["PHASE3"],"sponsor":{"text":"Mayo Clinic","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-10-09","start_date":"2025-02-03","link":{"text":"https://clinicaltrials.gov/study/NCT06693674","untrusted":true}},{"nct_id":"NCT07465653","title":{"text":"A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction","untrusted":true},"phase":["PHASE1"],"sponsor":{"text":"Novartis Pharmaceuticals","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-10-01","start_date":"2026-03-18","link":{"text":"https://clinicaltrials.gov/study/NCT07465653","untrusted":true}},{"nct_id":"NCT02966665","title":{"text":": Vascular Function in Health and Disease","untrusted":true},"phase":["PHASE1"],"sponsor":{"text":"D. Walter Wray","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-09-25","start_date":"2008-09","link":{"text":"https://clinicaltrials.gov/study/NCT02966665","untrusted":true}},{"nct_id":"NCT07491718","title":{"text":"Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy","untrusted":true},"phase":["NA"],"sponsor":{"text":"University of Edinburgh","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-09-18","start_date":"2025-08-08","link":{"text":"https://clinicaltrials.gov/study/NCT07491718","untrusted":true}}],"fact_id":"8e5e713c7f5bdf3f299ba4ca"}]},"spending":{"reported_under":{"generic":{"text":"Sacubitril/Valsartan","untrusted":true},"brand":{"text":"Entresto","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":1203043540,"claims":1502171,"beneficiaries":283074,"average_spending_per_claim_usd":800.86990096,"fact_id":"c548aa3f0a7b03decda51fea"},{"year":2021,"gross_spending_usd":1722714575.6,"claims":1937626,"beneficiaries":394848,"average_spending_per_claim_usd":889.08518756,"fact_id":"7173f9b76ce4eb49d7ae0bf4"},{"year":2022,"gross_spending_usd":2489531558.8,"claims":2527550,"beneficiaries":520839,"average_spending_per_claim_usd":984.95838215,"fact_id":"ce67b87f112dd69be30423f3"},{"year":2023,"gross_spending_usd":3430441590.4,"claims":3200200,"beneficiaries":663587,"average_spending_per_claim_usd":1071.9460004,"fact_id":"8b85fc3e60cadc1a8017af40"},{"year":2024,"gross_spending_usd":4020321686.4,"claims":3898804,"beneficiaries":795291,"average_spending_per_claim_usd":1031.1679393,"fact_id":"358d3ed9e689a76e973f2d60"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"medicaid_state_utilization":{"year":2025,"states_with_data":5,"all_states_medicaid_reimbursed_usd":369702.85,"all_states_medicaid_paid_prescriptions":580,"top_states":[{"state":"KY","medicaid_paid_prescriptions":145,"medicaid_reimbursed_usd":129499.89,"total_reimbursed_usd":129499.89,"packages":1,"covers":"fee_for_service_only","fact_id":"e31297b02549ac1e9b7b34bb"},{"state":"MO","medicaid_paid_prescriptions":219,"medicaid_reimbursed_usd":74765.22,"total_reimbursed_usd":74765.22,"packages":1,"covers":"all_record_types","fact_id":"05bf1ae93732b8fceb0ceda5"},{"state":"NV","medicaid_paid_prescriptions":66,"medicaid_reimbursed_usd":72460.67,"total_reimbursed_usd":85908.28,"packages":1,"covers":"fee_for_service_only","fact_id":"a652eb182c9cf8cafeb45290"},{"state":"MA","medicaid_paid_prescriptions":82,"medicaid_reimbursed_usd":54855.69,"total_reimbursed_usd":54855.69,"packages":1,"covers":"fee_for_service_only","fact_id":"de3a46c5d386bd57580c45ae"},{"state":"IA","medicaid_paid_prescriptions":68,"medicaid_reimbursed_usd":38121.38,"total_reimbursed_usd":38121.38,"packages":1,"covers":"all_record_types","fact_id":"f4e68cad40969cf4883d3338"}],"unlabelled_state_code_xx":null,"built_from_facts":5,"facts_fee_for_service_only":3,"older_year_facts_not_used":246,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"9243851f654d4f9cfffb646a","field":"ndc.listing","entity":"ndc:00078065920"},{"fact_id":"c35ddf0d75d69ceaf98e04da","field":"ndc.listing","entity":"ndc:00078065967"},{"fact_id":"d8ce87570ebc2aa478d54541","field":"ndc.listing","entity":"ndc:00078069620"},{"fact_id":"ad780dae2bf3036776f47a90","field":"ndc.nadac_price","entity":"ndc:00078065920"},{"fact_id":"1c3490d170642f9d81f90b37","field":"ndc.mfp","entity":"ndc:00078065920"},{"fact_id":"2f2f3f5569ef97a1e5bfb6aa","field":"ndc.mfp","entity":"ndc:00078065935"},{"fact_id":"14f656fb5a136ed44cefaadf","field":"ndc.mfp","entity":"ndc:00078065961"},{"fact_id":"d04f83c22b9155c5b659947d","field":"drug.generic_entry_earliest","entity":"application:NDA207620"},{"fact_id":"8f5954549f6ae75260564e12","field":"drug.patent","entity":"application:NDA207620"},{"fact_id":"6a54be5fc708906e6f3b2fa8","field":"drug.generic_entry_earliest","entity":"application:NDA218591"},{"fact_id":"1a5eb5ab0c90b1f3b13d9d08","field":"drug.patent","entity":"application:NDA218591"},{"fact_id":"05b98feef4d821ffeb684051","field":"drug.label_event","entity":"application:NDA207620"},{"fact_id":"903cd5e68f69c3a2bd4d02ad","field":"drug.label_event","entity":"application:NDA207620"},{"fact_id":"3f53e5837713dac6563724f6","field":"drug.label_event","entity":"application:NDA207620"},{"fact_id":"008ddf1e3a6e9c667ae3613e","field":"drug.label_event","entity":"application:NDA207620"},{"fact_id":"ca30d68701a941b817fc577c","field":"drug.te_code","entity":"application:NDA207620"},{"fact_id":"7d72964d1f3d38cd8991db42","field":"drug.marketing_status","entity":"application:NDA207620"},{"fact_id":"66a03e6915fbdbae4e76b9f0","field":"drug.te_code","entity":"application:NDA207620"},{"fact_id":"c7313ba1d486bbc2025c99b1","field":"drug.marketing_status","entity":"application:NDA207620"},{"fact_id":"4c2b7c729fad0de172ab4e68","field":"drug.te_code","entity":"application:NDA207620"},{"fact_id":"9296a75eb566898648382075","field":"drug.marketing_status","entity":"application:NDA207620"},{"fact_id":"529d0ac443263777f9bbfb33","field":"drug.marketing_status","entity":"application:NDA218591"},{"fact_id":"2e5cb1419811cc958e38478d","field":"drug.marketing_status","entity":"application:NDA218591"},{"fact_id":"8e5e713c7f5bdf3f299ba4ca","field":"drug.trial_access","entity":"drug:valsartan"},{"fact_id":"c548aa3f0a7b03decda51fea","field":"drug.partd_spending","entity":"drug:sacubitril-valsartan|entresto"},{"fact_id":"7173f9b76ce4eb49d7ae0bf4","field":"drug.partd_spending","entity":"drug:sacubitril-valsartan|entresto"},{"fact_id":"ce67b87f112dd69be30423f3","field":"drug.partd_spending","entity":"drug:sacubitril-valsartan|entresto"},{"fact_id":"8b85fc3e60cadc1a8017af40","field":"drug.partd_spending","entity":"drug:sacubitril-valsartan|entresto"},{"fact_id":"358d3ed9e689a76e973f2d60","field":"drug.partd_spending","entity":"drug:sacubitril-valsartan|entresto"},{"fact_id":"e31297b02549ac1e9b7b34bb","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078069667:KY"},{"fact_id":"05bf1ae93732b8fceb0ceda5","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078077767:MO"},{"fact_id":"a652eb182c9cf8cafeb45290","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078065967:NV"},{"fact_id":"de3a46c5d386bd57580c45ae","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078077767:MA"},{"fact_id":"f4e68cad40969cf4883d3338","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00078065967:IA"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["AMBER","GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"recalls","reason":"no FDA enforcement report naming a package of these applications is recorded"},{"code":"NO_DATA","field":"assistance_and_offers","reason":"no assistance program lists this drug and no manufacturer offer naming it is recorded; that does not mean none exists"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"AMBIGUOUS","field":"spending","reason":"2 brand and generic name pairs match; the series shown is the one with the newest year and the largest spending"},{"code":"NO_DATA","field":"biologic_status","reason":"no biologic application of this drug has a Purple Book status in the edition (a drug that is not a biologic has none)"},{"code":"NO_DATA","field":"payment_limit","reason":"no HCPCS code whose NDC crosswalk names a package of these applications has a Part B payment limit in the edition"},{"code":"NO_DATA","field":"rems","reason":"no REMS@FDA program is tied to these applications in the edition (most drugs have none)"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"orphan_designation","reason":"no FDA orphan designation for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}